• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA 损伤诱导的持续 p53 激活有助于大鼠炎症相关的肝癌发生。

DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats.

机构信息

1] Department of Cell and Neurobiology, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA [2] Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

出版信息

Oncogene. 2013 Sep 19;32(38):4565-71. doi: 10.1038/onc.2012.451. Epub 2012 Oct 15.

DOI:10.1038/onc.2012.451
PMID:23069657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3855850/
Abstract

The tumor suppressor p53 has an important role in inducing cell-intrinsic responses to DNA damage, including cellular senescence or apoptosis, which act to thwart tumor development. It has been shown, however, that senescent or dying cells are capable of eliciting inflammatory responses, which can have pro-tumorigenic effects. Whether DNA damage-induced p53 activity can contribute to senescence- or apoptosis-associated pro-tumorigenic inflammation is unknown. Recently, we generated a p53 knock-out rat via homologous recombination in rat embryonic stem cells. Here we show that in a rat model of inflammation-associated hepatocarcinogenesis, heterozygous deficiency of p53 resulted in attenuated inflammatory responses and ameliorated hepatic cirrhosis and tumorigenesis. Chronic administration of hepatocarcinogenic compound, diethylnitrosamine, led to persistent DNA damage and sustained induction of p53 protein in the wild-type livers, and much less induction in p53 heterozygous livers. Sustained p53 activation subsequent to DNA damage was accompanied by apoptotic rather than senescent hepatic injury, which gave rise to the hepatic inflammatory responses. In contrast, the non-hepatocarcinogenic agent, carbon tetrachloride, failed to induce p53, and caused a similar degree of chronic hepatic inflammation and cirrhosis in wild type and p53 heterozygous rats. These results suggest that although p53 is usually regarded as a tumor suppressor, its constant activation can promote pro-tumorigenic inflammation, especially in livers exposed to agents that inflict lasting mutagenic DNA damage.

摘要

抑癌基因 p53 在诱导细胞固有对 DNA 损伤的反应中起着重要作用,包括细胞衰老或凋亡,这可阻止肿瘤的发展。然而,已经表明衰老或死亡的细胞能够引发炎症反应,这可能具有促肿瘤发生的作用。DNA 损伤诱导的 p53 活性是否可以促进与衰老或凋亡相关的促肿瘤炎症尚不清楚。最近,我们通过同源重组在大鼠胚胎干细胞中生成了 p53 敲除大鼠。在这里,我们表明在炎症相关的肝癌发生大鼠模型中,p53 的杂合子缺失导致炎症反应减弱,肝纤维化和肿瘤发生得到改善。肝癌发生化合物二乙基亚硝胺的慢性给药导致野生型肝脏中持续的 DNA 损伤和 p53 蛋白的持续诱导,而在 p53 杂合子肝脏中诱导的 p53 蛋白则较少。DNA 损伤后持续的 p53 激活伴随着凋亡而不是衰老的肝损伤,从而引发了肝炎症反应。相比之下,非致癌剂四氯化碳未能诱导 p53,并导致野生型和 p53 杂合子大鼠中发生相似程度的慢性肝炎症和纤维化。这些结果表明,尽管 p53 通常被认为是一种肿瘤抑制基因,但它的持续激活可以促进促肿瘤炎症,特别是在暴露于造成持久致突变 DNA 损伤的试剂的肝脏中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/3855850/30c9ac0e7ed9/nihms533950f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/3855850/ba88e907ba7a/nihms533950f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/3855850/9944282245c0/nihms533950f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/3855850/47bce756b760/nihms533950f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/3855850/30c9ac0e7ed9/nihms533950f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/3855850/ba88e907ba7a/nihms533950f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/3855850/9944282245c0/nihms533950f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/3855850/47bce756b760/nihms533950f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67cf/3855850/30c9ac0e7ed9/nihms533950f4.jpg

相似文献

1
DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats.DNA 损伤诱导的持续 p53 激活有助于大鼠炎症相关的肝癌发生。
Oncogene. 2013 Sep 19;32(38):4565-71. doi: 10.1038/onc.2012.451. Epub 2012 Oct 15.
2
p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release.p53 通过诱导 HMGB1 释放促进炎症相关的肝癌发生。
J Hepatol. 2013 Oct;59(4):762-8. doi: 10.1016/j.jhep.2013.05.029. Epub 2013 May 25.
3
Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.p53 的诱导使 ATM 缺陷型小鼠对肝癌发生产生抗性。
Gastroenterology. 2010 Mar;138(3):1155-65.e1-2. doi: 10.1053/j.gastro.2009.11.008. Epub 2009 Nov 14.
4
Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.在p53基因缺失的Hep3B肝癌细胞中,pectenotoxin-2诱导细胞凋亡是通过诱导DR4/DR5、Egr-1和NAG-1,激活半胱天冬酶以及调节Bcl-2家族来介导的。
Oncol Rep. 2008 Feb;19(2):517-26.
5
Inhibition of histone methyltransferase G9a attenuates liver cancer initiation by sensitizing DNA-damaged hepatocytes to p53-induced apoptosis.组蛋白甲基转移酶 G9a 的抑制通过使 DNA 损伤的肝细胞对 p53 诱导的细胞凋亡敏感来减弱肝癌的发生。
Cell Death Dis. 2021 Jan 19;12(1):99. doi: 10.1038/s41419-020-03381-1.
6
Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.NOD2 蛋白在肝脏中促进肝癌发生发展的机制研究:通过 RIP2 介导的促炎反应和一种新型核自噬介导的 DNA 损伤机制。
J Hematol Oncol. 2021 Jan 7;14(1):9. doi: 10.1186/s13045-020-01028-4.
7
Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.IFNγ 缺失增强了 FXR 敲除小鼠的肝癌发生。
J Hepatol. 2012 Nov;57(5):1004-12. doi: 10.1016/j.jhep.2012.06.016. Epub 2012 Jun 21.
8
The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo.R246S热点p53突变体在体外和体内的胚胎干细胞中发挥显性负效应。
J Cell Sci. 2008 Jun 1;121(11):1899-906. doi: 10.1242/jcs.022822. Epub 2008 May 13.
9
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.v-Myb 禽成髓细胞瘤病毒致癌基因同源物样 2(MYBL2)-LIN9 复合物的激活有助于人类肝癌的发生,并确定了具有突变型 p53 的肝细胞癌亚群。
Hepatology. 2011 Apr;53(4):1226-36. doi: 10.1002/hep.24174.
10
Non-cell-autonomous tumor suppression by p53.p53 非细胞自主的肿瘤抑制作用。
Cell. 2013 Apr 11;153(2):449-60. doi: 10.1016/j.cell.2013.03.020. Epub 2013 Apr 4.

引用本文的文献

1
Inflammation in cancer: therapeutic opportunities from new insights.癌症中的炎症:新见解带来的治疗机遇
Mol Cancer. 2025 Feb 24;24(1):51. doi: 10.1186/s12943-025-02243-8.
2
Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients.多形性胶质母细胞瘤:对抗菌肽LL-37和PG-1的敏感性及其与化疗联合用于预测患者总生存期
Pharmaceutics. 2024 Sep 22;16(9):1234. doi: 10.3390/pharmaceutics16091234.
3
Mechanisms of Hook F on treating rheumatoid arthritis explored by network pharmacology analysis and molecular docking.

本文引用的文献

1
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.衰老监控良性前肝癌细胞可限制肝癌发生。
Nature. 2011 Nov 9;479(7374):547-51. doi: 10.1038/nature10599.
2
Tumor promotion via injury- and death-induced inflammation.通过损伤和死亡诱导的炎症促进肿瘤。
Immunity. 2011 Oct 28;35(4):467-77. doi: 10.1016/j.immuni.2011.09.006.
3
Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice.p53 表达的增加可诱导小鼠和人肝细胞合成 CTGF,并导致小鼠肝纤维化。
基于网络药理学分析和分子对接探究钩吻素子治疗类风湿关节炎的作用机制
Open Med (Wars). 2024 May 30;19(1):20240967. doi: 10.1515/med-2024-0967. eCollection 2024.
4
Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells.分子标志物的表达及抗菌肽联合化疗对神经胶质瘤细胞的协同抗癌作用。
Cancer Chemother Pharmacol. 2024 May;93(5):455-469. doi: 10.1007/s00280-023-04622-8. Epub 2024 Jan 27.
5
Early warning and diagnosis of liver cancer based on dynamic network biomarker and deep learning.基于动态网络生物标志物和深度学习的肝癌早期预警与诊断
Comput Struct Biotechnol J. 2023 Jul 4;21:3478-3489. doi: 10.1016/j.csbj.2023.07.002. eCollection 2023.
6
SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation.SOCS1缺陷通过依赖SOCS3的CDKN1A诱导和NRF2激活促进肝细胞癌。
Cancers (Basel). 2023 Jan 31;15(3):905. doi: 10.3390/cancers15030905.
7
The landscape of aging.衰老的景象。
Sci China Life Sci. 2022 Dec;65(12):2354-2454. doi: 10.1007/s11427-022-2161-3. Epub 2022 Sep 2.
8
In Vitro Evaluation of the Cytotoxic Effect of Strains, Protegrin PG-1, Cathelicidin LL-37, Nerve Growth Factor and Chemotherapy on the C6 Glioma Cell Line.体外评价 株、Protegrin PG-1、Cathelicidin LL-37、神经生长因子和化疗药物对 C6 神经胶质瘤细胞系的细胞毒性作用。
Molecules. 2022 Jan 17;27(2):569. doi: 10.3390/molecules27020569.
9
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.EP300 敲低降低三阴性乳腺癌中的癌症干细胞表型、肿瘤生长和转移。
BMC Cancer. 2020 Nov 10;20(1):1076. doi: 10.1186/s12885-020-07573-y.
10
Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.二乙基亚硝胺增加胰岛素治疗 1 型糖尿病小鼠肝癌发生早期的增殖。
Biomed Res Int. 2018 Apr 23;2018:9472939. doi: 10.1155/2018/9472939. eCollection 2018.
J Clin Invest. 2011 Aug;121(8):3343-56. doi: 10.1172/JCI44957. Epub 2011 Jul 11.
4
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
5
Production of p53 gene knockout rats by homologous recombination in embryonic stem cells.利用胚胎干细胞中的同源重组生产 p53 基因敲除大鼠。
Nature. 2010 Sep 9;467(7312):211-3. doi: 10.1038/nature09368. Epub 2010 Aug 11.
6
The first 30 years of p53: growing ever more complex.p53的头30年:愈发复杂
Nat Rev Cancer. 2009 Oct;9(10):749-58. doi: 10.1038/nrc2723.
7
Senescence of activated stellate cells limits liver fibrosis.活化星状细胞的衰老限制肝纤维化。
Cell. 2008 Aug 22;134(4):657-67. doi: 10.1016/j.cell.2008.06.049.
8
Altered expression of cell cycle and apoptotic proteins in chronic hepatitis C virus infection.慢性丙型肝炎病毒感染中细胞周期和凋亡蛋白的表达改变。
BMC Microbiol. 2008 Aug 5;8:133. doi: 10.1186/1471-2180-8-133.
9
Experimental models of hepatocellular carcinoma.肝细胞癌的实验模型
J Hepatol. 2008 May;48(5):858-79. doi: 10.1016/j.jhep.2008.01.008. Epub 2008 Jan 30.
10
Hepatocellular carcinoma pathogenesis: from genes to environment.肝细胞癌的发病机制:从基因到环境
Nat Rev Cancer. 2006 Sep;6(9):674-87. doi: 10.1038/nrc1934.